Selected
Publications
Sellmeyer DE, Black DM, Palermo L, Greenspan S, Ensrud K, Bilezikian J, Rosen CJ 2007 Hetereogeneity in skeletal response to full-length parathyroid hormone in the treatment of osteoporosis. Osteoporos Int 18:973-979
Lecka-Czernik B, Ackert-Bicknell C, Adamo ML, Marmolejos V, Churchill GA, Shockley KR, Reid IR, Grey A, Rosen CJ 2007 Activation of peroxisome proliferator-activated receptor gamma (PPARgamma) by rosiglitazone suppresses components of the insulin-like growth factor regulatory system in vitro and in vivo. Endocrinology 148:903-911
Recker R, Lips P, Felsenberg D, Lippuner K, Benhamou L, Hawkins F, Delmas PD, Rosen C, Emkey R, Salzmann G, He W, Santora AC 2006 Alendronate with and without cholecalciferol for osteoporosis: results of a 15-week randomized controlled trial. Curr Med Res Opin 22:1745-1755
Beamer WG, Shultz KL, Ackert-Bicknell CL, Horton LG, Delahunty KM, Coombs HF, Donahue LR, Canalis E, Rosen CJ 2007 Genetic Dissection of Mouse Distal Chromosome 1 Reveals Three Linked BMD QTL With Sex Dependent Regulation of Bone Phenotypes. J Bone Miner Res 22:1187-1196
Black DM, Rosen CJ 2007 Is risedronate or alendronate more effective at preventing nonvertebral fractures in women with osteoporosis? Nat Clin Pract Rheumatol 3:378-379
Shockley KR, Rosen CJ, Churchill GA, Lecka-Czernik B 2007 PPAR2 Regulates a Molecular signature of Marrow Mesenchymal Stem Cells. PPAR Research In Press:
Ackert-Bicknell CL, Salisbury JL, Horowitz M, DeMambro VE, Gorton LG, Shultz KL, Lecka-Czernik B, Rosen CJ 2007 A Chromosomal Inversion Within A Quantitative Trait Locus Has a Major Effect on Adipogenesis and Osteoblastogenesis. Ann. N.Y. Acad. Sci. xxx:1-55 DOI:10.1196/annals.1402.010 In Press
Flood A, Mai V, Pfeiffer R, Kahle L, Remaley AT, Rosen CJ, Lanza E, Schatzkin A 2007 The effects of a high-fruit and -vegetable, high-fiber, low-fat dietary intervention on serum concentrations of insulin, glucose, IGF-I and IGFBP-3. Eur J Clin Nutr, May 9.
Rosen CJ 2007 The Rosiglitazone Story – Lessons from an FDA Advisory Committee Meeting. N Engl J Med www.nejm.org August 8, 2007 10.1056/NEJMPO78167 |